It cannot detect DUX4 deregulation (which represents 7% of B-ALL), which has been considered an independent entity by the WHO 2022 and ICC 2022 classifications and confers favorable prognosis [18]. Here, DUX4 is linked to acute lymphoblastic leukemia.